| Literature DB >> 31999448 |
Thomas Siemon1, Zhangqian Wang2, Guangkai Bian2, Tobias Seitz1, Ziling Ye3, Yan Lu2, Shu Cheng2, Yunkun Ding2, Yanglei Huang2, Zixin Deng2,4, Tiangang Liu2,4, Mathias Christmann1.
Abstract
Herein, we report a short semisynthesis of the potent transient receptor potential canonical (TRPC) channel agonist englerin A (EA) and the related guaianes oxyphyllol and orientalol E. The guaia-6,10(14)-diene starting material was systematically engineered in Escherichia coli and Saccharomyces cerevisiae using the CRISPR/Cas9 system and was produced with high titers. The potentially scalable approach combines the advantages of synthetic biology and chemical synthesis providing an efficient and economical method for producing EA and analogues.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31999448 DOI: 10.1021/jacs.9b12940
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419